Search Results 1011-1020 of 17092 for monoclonal antibody

1. A Study of Adults 65 Years or Older to Establish Normal Lymphocyte Subsets and Immunoglobulin Levels - Mayo Clinic

   Current or previous treatment with biologics, monoclonal antibodies, or other immunosuppressive treatment (due to possibility of secondary immunodeficiency).

2. Study shows drug reduces risk of relapse with neuromyelitis optica - Mayo Clinic News Network

   ROCHESTER, Minn. — The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with ...

3. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   Part 2 (Cohort Expansion): Subjects must have received adequate prior therapy including at a minimum including at a minimum anti-CD20 monoclonal antibody ...

4. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

   At any time received any monoclonal antibody (including biosimilars) targeting TNFα, IL-12, or IL-23, or anti-integrin agents approved for CD (i.e. ...

5. This immunofluorescence photomicrograph uses the dye, fluorescein, attached to an antibody specific for a protein in eosinophil granules, called eosinophil ...

6. A Study to Evaluate Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma - Mayo Clinic

   Known hypersensitivity to platinum, paclitaxel, another monoclonal antibody, or any of the excipients that cannot be controlled with standard measures (e.g., ...

7. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   ... monoclonal antibody, including humanized or chimeric antibodies. Subject has ... For subjects who are negative for HBs Ag, but Hepatitis B core antibody ...

8. Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot) - Mayo Clinic

   ... antibody levels observed following Flu-IVIG transfusion are similar to those predicted. This pilot study will inform a larger study that will be powered to ...

9. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   ... monoclonal antibody (MetMAb); prior antibody therapy such as bevacizumab or cetuximab is allowed with a washout period depending on dosing interval and ...

10. Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) - Mayo Clinic

    Prior systemic therapy (eg, chemotherapy, immunomodulatory therapy, or monoclonal antibody therapy) within 3 weeks prior or 5 half-lives of the drug, whichever ...